Loading people...
L. John Wilkerson is the Founder and Senior Advisor at Galen Partners, a healthcare private equity firm based in Stamford, Connecticut. He began his early career as a Group Product Director at Johnson and Johnson before serving as a Vice President of medical analysis at Smith Barney. Wilkerson later purchased and expanded the consultancy Channing, Weinberg and Company into The Wilkerson Group, which he eventually sold to IBM. Since co-founding Galen Partners in 1990, he has helped manage over $1 billion across multiple funds and directed investments into more than 80 healthcare companies. He has also held board positions at numerous portfolio entities, including Stericycle, MedAssets, and British Biotechnology. Holding a doctorate in managerial economics from Cornell University, Wilkerson maintains a dedicated focus on scaling revenue-stage healthcare enterprises to advance medical technology and clinical services.
L. John Wilkerson stands as a highly respected Managing Director and co-founder of Galen Partners, a leading private equity firm exclusively dedicated to the healthcare industry. Since co-founding Galen Partners in 1990, Mr. Wilkerson has been instrumental in shaping the firm's investment strategy and fostering its success as a premier growth equity investor in the healthcare sector.
At Galen Partners, L. John Wilkerson's primary role involves providing strategic leadership, overseeing investment decisions, and actively engaging with portfolio companies. His investment focus is squarely on growth equity opportunities within middle-market healthcare companies. He targets businesses across a broad spectrum of healthcare sub-sectors, including healthcare services, medical devices, diagnostics, healthcare information technology (IT), and digital health solutions. Mr. Wilkerson is particularly interested in companies that possess proven business models, strong management teams, and significant potential for market expansion and value creation.
Mr. Wilkerson's extensive career background provides a deep well of expertise that informs his investment approach. Prior to establishing Galen Partners, he held a distinguished position as a Managing Director at The First Boston Corporation, where he notably headed the firm's healthcare group. His tenure in investment banking involved significant work in mergers and acquisitions (M&A), corporate finance, and strategic advisory services for a diverse range of healthcare clients. This foundational experience equipped him with an unparalleled understanding of the complex financial and operational dynamics within the healthcare market, enabling him to identify promising ventures and guide them toward sustainable growth.
Throughout his career, L. John Wilkerson has been a proponent of a hands-on investment philosophy. He believes in partnering closely with entrepreneurs and management teams, offering not just capital but also strategic guidance, operational insights, and access to a vast network of industry contacts. This collaborative approach is designed to enhance operational efficiencies, accelerate market penetration, and ultimately drive substantial value creation for Galen's portfolio companies. His contributions have been pivotal in the growth and successful exits of numerous innovative healthcare enterprises, solidifying his reputation as a visionary leader in healthcare private equity.
L. John Wilkerson's enduring commitment to the healthcare investment sector and his profound expertise continue to make him a key figure at Galen Partners and a significant influencer in the evolution of healthcare innovation.
L. John Wilkerson is a Managing Director and co-founder of Galen Partners, a prominent private equity firm focused exclusively on growth equity investments within the healthcare industry.
L. John Wilkerson invests in growth equity opportunities within middle-market healthcare companies. His focus areas include healthcare services, medical devices, diagnostics, healthcare information technology (IT), and digital health solutions.
L. John Wilkerson works as a Managing Director at Galen Partners, a leading healthcare-focused private equity firm he co-founded.
